Abstract |
Activation of Akt ( protein kinase B), a Ser/Thr protein kinase that promotes cell survival, has been linked to tumorigenesis. Akt is activated by phosphorylation after binding of its pleckstrin homology (PH) domain to plasma membrane phosphatidyl-myo-inositol-3-phosphates, formed by phosphoinositide-3-kinase. We report a novel strategy to inhibit Akt activation based on the use of D-3-deoxy-phosphatidyl-myo-inositols (DPIs) that cannot be phosphorylated on the 3-position of the myo- inositol ring. We have studied the DPIs, DPI 1-[(R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate], its ether lipid derivative DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl hydrogen phosphate] (DPIEL), and its carbonate derivative DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl carbonate]. We demonstrate in platelet-derived growth factor-stimulated mouse NIH3T3 cells that the DPIs bind to the PH domain of Akt, trapping it in the cytoplasm and thus preventing Akt activation. DPIEL did not inhibit myristylated-Akt, a constitutively active membrane-bound Akt expressed in NIH3T3 cells, and cell growth was not inhibited, unlike in wild-type NIH3T3 cells. Molecular modeling and docking studies show that DPIEL binds with much higher affinity to Akt's PH domain as compared with DPI and DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl carbonate]. This study shows that the DPIs are a novel class of growth inhibitory agents with a novel mechanism of action through binding to the PH domain of Akt and inhibition of Akt activation.
|
Authors | Emmanuelle J Meuillet, Daruka Mahadevan, Hariprasad Vankayalapati, Margareta Berggren, Ryan Williams, Amy Coon, Alan P Kozikowski, Garth Powis |
Journal | Molecular cancer therapeutics
(Mol Cancer Ther)
Vol. 2
Issue 4
Pg. 389-99
(Apr 2003)
ISSN: 1535-7163 [Print] United States |
PMID | 12700283
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Blood Proteins
- Enzyme Inhibitors
- Myristic Acids
- Phosphatidylinositols
- Phosphoproteins
- Proto-Oncogene Proteins
- platelet protein P47
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins c-akt
|
Topics |
- Animals
- Apoptosis
- Binding Sites
- Blood Proteins
(chemistry)
- Cell Division
- Cell Line, Tumor
- Cell Membrane
(metabolism)
- Dose-Response Relationship, Drug
- Enzyme Activation
- Enzyme Inhibitors
(pharmacology)
- Lipid Metabolism
- Mice
- Models, Biological
- Models, Chemical
- Models, Molecular
- Myristic Acids
(metabolism)
- NIH 3T3 Cells
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphatidylinositols
(chemistry, pharmacology)
- Phosphoproteins
(chemistry)
- Phosphorylation
- Protein Binding
- Protein Serine-Threonine Kinases
(antagonists & inhibitors, chemistry)
- Protein Structure, Tertiary
- Protein Transport
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-akt
- Transfection
|